Kang‐Yung Peng

1.6k citations

60 papers · 1.3k indexed · h-index 23

Electrical and Electronic Engineering top 5%
Polymers and Plastics top 5%
Materials Chemistry
Endocrinology, Diabetes and Metabolism top 5%
Surgery top 10%

Co-authors: Show‐An Chen Wunshain Fann S. A. Chen Vin‐Cent Wu A. C. Su Anto R. Inigo Yen‐Hung Lin J. D. White
Topics: Hormonal Regulation and Hypertension (29 papers)Adrenal and Paraganglionic Tumors (24 papers)Organic Electronics and Photovoltaics (22 papers)
Cited by: Polymers and Plastics Endocrinology, Diabetes and Metabolism Electrical and Electronic Engineering
Journals: Journal of the American Chemical Society Physical Review Letters Advanced Materials
Partner nations: Taiwan United States China

In The Last Decade

Kang‐Yung Peng

58 papers receiving 1.2k citations

Peers

Countries citing papers authored by Kang‐Yung Peng

Since Specialization

Citations

This map shows the geographic impact of Kang‐Yung Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang‐Yung Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang‐Yung Peng more than expected).

Fields of papers citing papers by Kang‐Yung Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kang‐Yung Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang‐Yung Peng. The network helps show where Kang‐Yung Peng may publish in the future.

Co-authorship network of co-authors of Kang‐Yung Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Kang‐Yung Peng. A scholar is included among the top collaborators of Kang‐Yung Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kang‐Yung Peng. Kang‐Yung Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	C-terminal FGF-23 production coupling with aldosterone via FAM20C and predicting cardiovascular events in primary aldosteronism 2025 ·JCI Insight ·Vin‐Cent Wu,Kang‐Yung Peng,(unknown),Chiao-Yin Sun,Hung‐Wei Liao,Chieh‐Kai Chan,Yen‐Hung Lin,(unknown),Shih‐Chieh Chueh	1
2	The predictors of long-term outcomes after targeted therapy for primary Aldosteronism 2023 ·Journal of the Formosan Medical Association ·(unknown),Shun‐Chen Huang,Chien‐Ting Pan,Kang‐Yung Peng,Liang‐Yu Lin,Chieh‐Kai Chan,Chia‐Tung Shun	1
3	Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism 2023 ·Journal of the Formosan Medical Association ·Chi‐Shin Tseng,Chieh‐Kai Chan,Hsiang‐Ying Lee,Chien‐Ting Pan,Kang‐Yung Peng,Shuo‐Meng Wang,Kuo‐How Huang,Yao‐Chou Tsai,Vin‐Cent Wu,Shih‐Chieh Chueh	8
4	Circulating Plasma Concentrations of ACE2 in Primary Aldosteronism and Cardiovascular Outcomes 2022 ·The Journal of Clinical Endocrinology & Metabolism ·Vin‐Cent Wu,Kang‐Yung Peng,(unknown),Chin‐Chen Chang,Chieh‐Kai Chan,Tai‐Shuan Lai,Yen‐Hung Lin,Shuo‐Meng Wang,Ching‐Chu Lu,Yu-Chun Liu,Yao‐Chou Tsai,Shih‐Chieh Chueh	1
5	A Novel Somatic Mutation of CACNA1H p.V1937M in Unilateral Primary Hyperaldosteronism 2022 ·Frontiers in Endocrinology ·Chi‐Shin Tseng,Kang‐Yung Peng,Shuo‐Meng Wang,Yao‐Chou Tsai,Kuo‐How Huang,Wei‐Chou Lin,Ya‐Hui Hu,Vin‐Cent Wu,Shih‐Chieh Chueh	3
6	Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology 2022 ·Frontiers in Endocrinology ·Yi–Ju Chen,Kang‐Yung Peng,Shih‐Chieh Chueh,Hung‐Wei Liao,(unknown),Vin‐Cent Wu,Shuo‐Meng Wang	5
7	Characteristics and Outcomes in Primary Aldosteronism Patients Harboring Glucocorticoid-Remediable Aldosteronism 2021 ·Biomedicines ·(unknown),Hung‐Wei Liao,Kang‐Yung Peng,(unknown),Yen‐Hung Lin,Shih‐Chieh Chueh,Vin‐Cent Wu,(unknown)	4
8	KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated with a Greater Recovery of Arterial Stiffness 2021 ·Cancers ·Yi‐Yao Chang,Chien‐Ting Pan,Zheng‐Wei Chen,Cheng‐Hsuan Tsai,(unknown),Chin‐Chen Chang,Bo‐Ching Lee,Che‐Wei Liao,Kang‐Yung Peng,(unknown),Chia‐Hung Chou,Vin‐Cent Wu,Liyu Liu,Chi‐Sheng Hung,Yen‐Hung Lin	6
9	Pathophysiological and Pharmacological Characteristics of KCNJ5 157-159delITE Somatic Mutation in Aldosterone-Producing Adenomas 2021 ·Biomedicines ·Kang‐Yung Peng,Hung‐Wei Liao,Shih‐Chieh Chueh,Chien‐Yuan Pan,Yen‐Hung Lin,Yung‐Ming Chen,(unknown),Chun‐Lin Huang,Vin‐Cent Wu	4
10	Novel Mutations Detection with Next-Generation Sequencing and Its Association with Clinical Outcome in Unilateral Primary Aldosteronism 2021 ·Biomedicines ·Che‐Hsiung Wu,Kang‐Yung Peng,Daw‐Yang Hwang,Yen‐Hung Lin,Vin‐Cent Wu,Shih‐Chieh Chueh	7
11	GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism 2021 ·BMC Bioinformatics ·Yu‐Ching Wu,(unknown),(unknown),(unknown),(unknown),Kang‐Yung Peng,Vin‐Cent Wu,Jyy-Jih Tsai-Wu,Chia‐Lang Hsu,(unknown)	2
12	NP-59 Adrenal Scintigraphy as an Imaging Biomarker to Predict KCNJ5 Mutation in Primary Aldosteronism Patients 2021 ·Frontiers in Endocrinology ·Ching‐Chu Lu,Ruoh‐Fang Yen,Kang‐Yung Peng,(unknown),Kwan‐Dun Wu,Shih‐Chieh Chueh,Wan‐Yu Lin	4
13	KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated With a Worse Baseline Status and Better Recovery of Left Ventricular Remodeling and Diastolic Function 2020 ·Hypertension ·Yi‐Yao Chang,Cheng‐Hsuan Tsai,(unknown),Zheng‐Wei Chen,Chin‐Chen Chang,Bo‐Ching Lee,Che‐Wei Liao,Chien‐Ting Pan,Yali Chen,Lung‐Chun Lin,(unknown),Kang‐Yung Peng,Chia‐Hung Chou,Vin‐Cent Wu,Chi‐Sheng Hung,Yen‐Hung Lin,(unknown)	20
14	Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism 2020 ·Endocrinology and Metabolism ·(unknown),Kang‐Yung Peng,Chia‐Hui Chang,Ya‐Hui Hu,Vin‐Cent Wu,Shiu‐Dong Chung,(unknown)	10
15	Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population 2015 ·Scientific Reports ·Vin‐Cent Wu,Kuo‐How Huang,Kang‐Yung Peng,Yao‐Chou Tsai,Che‐Hsiung Wu,Shuo‐Meng Wang,Shao‐Yu Yang,Lian‐Yu Lin,Chin‐Chen Chang,Yen‐Hung Lin,Shuei‐Liong Lin,Tzong‐Shinn Chu,Kwan‐Dun Wu	77
16	Hemojuvelin Modulates Iron Stress During Acute Kidney Injury: Improved by Furin Inhibitor 2013 ·Antioxidants and Redox Signaling ·Guang‐Huar Young,Tao‐Min Huang,Che‐Hsiung Wu,Chun‐Fu Lai,Chun‐Cheng Hou,Kang‐Yung Peng,Chan‐Jung Liang,Shuei‐Liong Lin,Shih‐Chung Chang,Hung‐Bin Tsai,Kwan‐Dun Wu,Vin‐Cent Wu,Wen‐Je Ko,(unknown)	22
17	Antiosteoporotic Activity of Dioscorea alata L. cv. Phyto through Driving Mesenchymal Stem Cells Differentiation for Bone Formation 2011 ·Evidence-based Complementary and Alternative Medicine ·Kang‐Yung Peng,(unknown),(unknown),Hui‐Chuan Huang,Rong-Tsun Wu	19
18	Hepatocyte growth factor has a role in the amelioration of diabetic vascular complications via autophagic clearance of advanced glycation end products: Dispo85E, an HGF inducer, as a potential botanical drug 2010 ·Metabolism ·Kang‐Yung Peng,(unknown),(unknown),Hui‐Chuan Huang,Rong-Tsun Wu	19
19	Aggregate versus Excimer Emissions from Poly(2,5-di-n-octyloxy-1,4-phenylenevinylene) 2007 ·The Journal of Physical Chemistry C ·(unknown),Y. J. Shiu,Jui Hsu,S. H. Lin,A. C. Su,Kang‐Yung Peng,S. A. Chen,Wunshain Fann	36
20	Well-Packed Chains and Aggregates in the Emission Mechanism of Conjugated Polymers 2005 ·The Journal of Physical Chemistry B ·Kang‐Yung Peng,Show‐An Chen,Wunshain Fann,Suhua Chen,An‐Chung Su	53

About Kang‐Yung Peng

Kang‐Yung Peng is a scholar working on Endocrinology, Diabetes and Metabolism, Polymers and Plastics and Surgery, having authored 60 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (29 papers), Adrenal and Paraganglionic Tumors (24 papers) and Organic Electronics and Photovoltaics (22 papers). The work is most often cited by research in Polymers and Plastics (519 citations), Endocrinology, Diabetes and Metabolism (321 citations) and Electrical and Electronic Engineering (710 citations). Kang‐Yung Peng has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Show‐An Chen, Wunshain Fann, S. A. Chen, Vin‐Cent Wu, A. C. Su, Anto R. Inigo, Yen‐Hung Lin, J. D. White, Shih‐Chieh Chueh and Kuo‐How Huang. Their work appears in journals such as Journal of the American Chemical Society, Physical Review Letters and Advanced Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact